Matae Ahn

Dr. Matae Ahn

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2021 in Nature
Verified
Journal Article
Closed access
PDF file
AIAaron T. Irving
Aaron T. Irving
MAMatae Ahn
Matae Ahn
GGGeraldine Goh
Geraldine Goh
DADanielle Anderson
Danielle Anderson
LWLin-Fa Wang
Lin-Fa Wang

25 February 2019 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
MAMatae Ahn
Matae Ahn
DADanielle Anderson
Danielle Anderson
QZQian Zhang
Qian Zhang
CTChee Wah Tan
Chee Wah Tan
BLBeng Lee Lim
Beng Lee Lim
LWLin-Fa Wang
Lin-Fa Wang

26 October 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
GGGeraldine Goh
Geraldine Goh
MAMatae Ahn
Matae Ahn
FZFeng Zhu
Feng Zhu
LLLim Beng Lee
Lim Beng Lee
DLDahai Luo
Dahai Luo
LWLin-Fa Wang
Lin-Fa Wang
Significance: Bats have been shown to dampen several key upstream pathogen and danger-associated molecular patterns, yet much of the downstream signaling is yet unknown. Here, we identify residues in caspase-1 which are critical for enzymatic activity and have been targeted for inhibition in Pteropus bats. Further, we discover cleavage-site flanking residues which lead to loss of IL-1β cleavage in Myotis bats. Thus, we report an inverse relationship between caspase-1 function and IL-1β cleavage, resulting in a consistent reduction of downstream signaling by the inflammasome across bats within the two suborders. In sum, we confirm that bats have targeted the inflammasome pathway at multiple levels and via heterogeneous strategies to reduce proinflammatory responses, thus mitigating potential immune-mediated tissue damage and disease.

11 May 2023 in Cell
Verified
Journal Article
Closed access
MAMatae Ahn
Matae Ahn
VCVivian Chih-Wei Chen
Vivian Chih-Wei Chen
PRPritisha Rozario
Pritisha Rozario
WNWei Lun Ng
Wei Lun Ng
PKPui San Kong
Pui San Kong
LWLin-Fa Wang
Lin-Fa Wang

8 November 2022 in Immunity
Verified
Journal Article
Closed access
AGAkshamal M. Gamage
Akshamal M. Gamage
WCWharton O.Y. Chan
Wharton O.Y. Chan
FZFeng Zhu
Feng Zhu
YLYan Ting Lim
Yan Ting Lim
SLSandy Long
Sandy Long
LWLin-Fa Wang
Lin-Fa Wang

12 October 2022 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
QSQi Su
Qi Su
WNWei Lun Ng
Wei Lun Ng
SGSuh Yee Goh
Suh Yee Goh
MGMuhammad Yaaseen Gulam
Muhammad Yaaseen Gulam
LWLin-Fa Wang
Lin-Fa Wang
YCYin Xia Chao
Yin Xia Chao
Parkinson’s disease (PD) is one of the most common neurodegenerative diseases in which neuroinflammation plays pivotal roles. An important mechanism of neuroinflammation is the NLRP3 inflammasome activation that has been implicated in PD pathogenesis. In this perspective, we will discuss the relationship of some key PD-associated proteins including α-synuclein and Parkin and their contribution to inflammasome activation. We will also review promising inhibitors of NLRP3 inflammasome pathway that have potential as novel PD therapeutics. Finally, we will provide a summary of current and potential in vitro and in vivo models that are available for therapeutic discovery and development.